healthsystemCIO.com is the sole online-only publication dedicated to exclusively and comprehensively serving the information needs of healthcare CIOs.
When leveraged for their original purpose – to “create a skeleton note for humans to augment and edit, reducing administrative burden – generative AI can help provide more time for patient care and clinical decision making, according to John Halamka, MD, and Paul Cerrato of Mayo Clinic Platform.
Large language models offer great potential for improving care and efficiency, but “that must be done within guardrails and guidelines so that we do no digital harm,” said Paul Cerrato and John Halamka, MD. In this piece, they discuss the key components for successful development and deployment of AI tools.
If digital tools don’t solve the problems they’re designed to solve – or worse, “do more harm than good” – they aren’t much good to healthcare organizations, said John Halamka, MD, and Paul Cerrato. The key, they believe, is in constant validation and earning the trust of stakeholders.
Through partnerships with health systems, payers, medical device companies, and academic medical centers, Mayo Clinic Platform_Connect aims to find better ways to diagnose, treat, and prevent disease, according to John Halamka, MD. How? “By connecting clinical data through a federated, secure architecture.”
Large language models and GPT may not be the apocalyptic nightmare some critics fear, but they certainly require due diligence by thought leaders, health care professionals, and the general public, wrote John Halamka, MD, and Paul Serrato. “We need a framework to manage them responsively.”
